Literature DB >> 23591444

Chronic kidney disease: Cystatin-C-based eGFR: what is it telling us?

Kristen L Jablonski1, Michel Chonchol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23591444     DOI： 10.1038/nrneph.2013.77

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Filtration markers may have prognostic value independent of glomerular filtration rate.

Authors:  Navdeep Tangri; Lesley A Inker; Hocine Tighiouart; Eric Sorensen; Vandana Menon; Gerald Beck; Michael Shlipak; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2011-12-15       Impact factor: 10.121

2.  Estimated GFR associates with cardiovascular risk factors independently of measured GFR.

Authors:  Ulla Dorte Mathisen; Toralf Melsom; Ole C Ingebretsen; Trond Jenssen; Inger Njølstad; Marit D Solbu; Ingrid Toft; Bjørn O Eriksen
Journal:  J Am Soc Nephrol       Date:  2011-03-31       Impact factor: 10.121

3.  Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Authors:  Michael G Shlipak; Ronit Katz; Mark J Sarnak; Linda F Fried; Anne B Newman; Catherine Stehman-Breen; Stephen L Seliger; Brian Kestenbaum; Bruce Psaty; Russell P Tracy; David S Siscovick
Journal:  Ann Intern Med       Date:  2006-08-15       Impact factor: 25.391

4.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

5.  Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes.

Authors:  Salman Waheed; Kunihiro Matsushita; Brad C Astor; Ron C Hoogeveen; Christie Ballantyne; Josef Coresh
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

6.  Serum cystatin C-based formulas for prediction of glomerular filtration rate in patients with chronic kidney disease.

Authors:  Radovan Hojs; Sebastjan Bevc; Robert Ekart; Maksimiljan Gorenjak; Ludvik Puklavec
Journal:  Nephron Clin Pract       Date:  2009-11-03

7.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

8.  Factors other than glomerular filtration rate affect serum cystatin C levels.

Authors:  Lesley A Stevens; Christopher H Schmid; Tom Greene; Liang Li; Gerald J Beck; Marshall M Joffe; Marc Froissart; John W Kusek; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  Kidney Int       Date:  2008-12-31       Impact factor: 10.612

9.  Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease.

Authors:  Andrew D Rule; Kent R Bailey; John C Lieske; Patricia A Peyser; Stephen T Turner
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612
  9 in total
  1 in total

1.  Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease.

Authors:  Kassia S Beetham; Erin J Howden; Nicole M Isbel; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2018-12-18       Impact factor: 2.388
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.